Related Experiment Video
Updated: Jun 1, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant
Andie S Lee1, Marina Macedo-Vinas, Patrice François
1Infection Control Program, Department of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney, Australia.
Background:
The clinical importance of low-level mupirocin resistance and genotypic chlorhexidine resistance remains unclear. We aimed to determine whether resistance to these agents increases the risk of persistent methicillin-resistant Staphylococcus aureus (MRSA) carriage after their use for topical decolonization therapy.
Methods:
A nested case-control study was conducted of MRSA carriers who received decolonization therapy from 2001 through 2008. Cases, patients who remained colonized, were matched by year to controls, those in whom MRSA was eradicated (follow-up, 2 years). Baseline MRSA isolates were tested for mupirocin resistance by Etest and chlorhexidine resistance by qacA/B polymerase chain reaction. MRSA carriers with high-level mupirocin resistance were excluded. The effect of the primary exposure of interest, low-level mupirocin and genotypic chlorhexidine resistance, was evaluated with multivariate conditional logistic regression analysis.
Results:
The 75 case patients and 75 control patients were similar except that those persistently colonized were older (P = .007) with longer lengths of hospital stay (P = .001). After multivariate analysis, carriage of combined low-level mupirocin and genotypic chlorhexidine resistance before decolonization independently predicted persistent MRSA carriage (odds ratio [OR], 3.4 [95% confidence interval {CI}, 1.5-7.8]). Other risk factors were older age (OR, 1.04 [95% CI, 1.02-1.1]), previous hospitalization (OR, 2.4 [95% CI, 1.1-5.7]), presence of a skin wound (OR, 5.7 [95% CI, 1.8-17.6]), recent antibiotic use (OR, 3.1 [95% CI, 1.3-7.2]), and central venous catheterization (OR, 5.7 [95% CI, 1.4-23.9]).
Conclusions:
Combined low-level mupirocin and genotypic chlorhexidine resistance significantly increases the risk of persistent MRSA carriage after decolonization therapy. Institutions with widespread use of these agents should monitor for resistance and loss of clinical effectiveness.
Insights
Low-level mupirocin and chlorhexidine resistance predict persistent MRSA carriage. Monitoring resistance is crucial for effective decolonization therapy and preventing MRSA spread.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- The clinical significance of low-level mupirocin resistance and genotypic chlorhexidine resistance in Staphylococcus aureus (MRSA) is not well understood.
- Topical decolonization therapy is used to treat MRSA carriage, but resistance may impact its effectiveness.
Purpose of the Study:
- To investigate if resistance to mupirocin and chlorhexidine increases the risk of persistent MRSA carriage after decolonization therapy.
- To identify risk factors associated with persistent MRSA colonization.
Main Methods:
- A nested case-control study of MRSA carriers undergoing decolonization therapy (2001-2008).
- Cases (persistent colonization) were matched to controls (MRSA eradication).
- Baseline MRSA isolates were tested for low-level mupirocin resistance and genotypic chlorhexidine resistance (qacA/B PCR).
Main Results:
- Combined low-level mupirocin and genotypic chlorhexidine resistance independently predicted persistent MRSA carriage (OR, 3.4).
- Other risk factors included older age, previous hospitalization, skin wounds, recent antibiotic use, and central venous catheterization.
- Persistent colonization was associated with older age and longer hospital stays.
Conclusions:
- Combined low-level mupirocin and genotypic chlorhexidine resistance significantly elevates the risk of persistent MRSA carriage post-decolonization.
- Healthcare institutions should monitor for these resistance mechanisms to ensure the clinical effectiveness of decolonization strategies.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Microbiota Modulation by Antibiotics
Antimicrobial Effectiveness
Hand hygiene
Hand washing...
Development of Antibiotic Resistance